137 related articles for article (PubMed ID: 26343958)
21. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
[TBL] [Abstract][Full Text] [Related]
22. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M
Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.
Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F
Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453
[TBL] [Abstract][Full Text] [Related]
24. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD34 in cirrhotic liver--reliance to dedifferentiation.
Gligorijević J; Djordjević B; Petrović A; Radirević A; Stojanović S
Vojnosanit Pregl; 2010 Jun; 67(6):459-62. PubMed ID: 20629423
[TBL] [Abstract][Full Text] [Related]
26. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.
Di Tommaso L; Destro A; Seok JY; Balladore E; Terracciano L; Sangiovanni A; Iavarone M; Colombo M; Jang JJ; Yu E; Jin SY; Morenghi E; Park YN; Roncalli M
J Hepatol; 2009 Apr; 50(4):746-54. PubMed ID: 19231003
[TBL] [Abstract][Full Text] [Related]
27. Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits.
Marquardt JU; Seo D; Andersen JB; Gillen MC; Kim MS; Conner EA; Galle PR; Factor VM; Park YN; Thorgeirsson SS
J Hepatol; 2014 Feb; 60(2):346-353. PubMed ID: 24512821
[TBL] [Abstract][Full Text] [Related]
28. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.
Park YN; Kojiro M; Di Tommaso L; Dhillon AP; Kondo F; Nakano M; Sakamoto M; Theise ND; Roncalli M
Cancer; 2007 Mar; 109(5):915-23. PubMed ID: 17279586
[TBL] [Abstract][Full Text] [Related]
29. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
30. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance.
Choi BI; Lee JM; Kim TK; Dioguardi Burgio M; Vilgrain V
AJR Am J Roentgenol; 2015 Jul; 205(1):10-21. PubMed ID: 26102378
[TBL] [Abstract][Full Text] [Related]
31. Early hepatocellular carcinoma and dysplastic nodules.
Kojiro M; Roskams T
Semin Liver Dis; 2005; 25(2):133-42. PubMed ID: 15918142
[TBL] [Abstract][Full Text] [Related]
32. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
Tremosini S; Forner A; Boix L; Vilana R; Bianchi L; Reig M; Rimola J; Rodríguez-Lope C; Ayuso C; Solé M; Bruix J
Gut; 2012 Oct; 61(10):1481-7. PubMed ID: 22287594
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers.
Uthamalingam P; Das A; Behra A; Kalra N; Chawla Y
J Clin Exp Hepatol; 2018 Jun; 8(2):173-180. PubMed ID: 29892181
[TBL] [Abstract][Full Text] [Related]
34. [Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].
DU JL; Wei LX; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):11-6. PubMed ID: 21429352
[TBL] [Abstract][Full Text] [Related]
35. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
[TBL] [Abstract][Full Text] [Related]
36. Hepatocarcinogenesis of regenerative and dysplastic nodules in Chinese patients.
Ng CH; Chan SW; Lee WK; Lai L; Lok KH; Li KK; Luk SH; Szeto ML
Hong Kong Med J; 2011 Feb; 17(1):11-9. PubMed ID: 21282821
[TBL] [Abstract][Full Text] [Related]
37. Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules.
Luo Q; Zhang Y; Wang N; Jin G; Jin H; Gu D; Tao X; Huo X; Ge T; Cong W; Wang C; Qin W
Oncotarget; 2015 Mar; 6(9):6989-99. PubMed ID: 25749520
[TBL] [Abstract][Full Text] [Related]
38. Hepatocarcinogenesis: imaging-pathologic correlation.
Park YN; Kim MJ
Abdom Imaging; 2011 Jun; 36(3):232-43. PubMed ID: 21267560
[TBL] [Abstract][Full Text] [Related]
39. Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis.
Liao Z; Tang C; Luo R; Gu X; Zhou J; Gao J
Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046429
[TBL] [Abstract][Full Text] [Related]
40. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification.
Roncalli M; Roz E; Coggi G; Di Rocco MG; Bossi P; Minola E; Gambacorta M; Borzio M
Hepatology; 1999 Nov; 30(5):1174-8. PubMed ID: 10534338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]